RxDoctor Payments Data

Justin Stark, DO

Family Medicine · Orange Park, FLNPI 1093087579

Payments from drug & device makers

$1,398in general payments, 2019–2025

Across 83 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$493
  • Amgen$194
  • GSK$168
  • Pfizer$158
  • AbbVie$125
  • Lilly USA, LLC$81
  • plus $180 from 9 others

What the payments were for

  • Food & beverage$1,398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,398 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$226,937
Medicare patients
463
Services billed
5,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$95,868
EliquisApixaban85$95,219
JardianceEmpagliflozin56$65,242
JanuviaSitagliptin Phosphate38$48,765
XareltoRivaroxaban27$35,204
MounjaroTirzepatide24$25,999
MyrbetriqMirabegron11$16,606
Breo ElliptaFluticasone/Vilanterol17$7,097
FarxigaDapagliflozin Propanediol11$5,904
Atorvastatin Calcium602$5,248
SynthroidLevothyroxine Sodium48$4,025
Gabapentin147$3,412
Amlodipine Besylate431$3,023
Duloxetine Hcl74$2,935
Omeprazole133$2,621

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$493$95,86882 claims
PfizerEliquis$158$95,21985 claims
Boehringer IngelheimJardiance$21$65,24256 claims
Lilly USA, LLCMounjaro$81$25,99924 claims
GSKBreo Ellipta$168$7,09717 claims
AbbVieSynthroid$125$4,02548 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orange Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →